Klocalm-Plus Tablet contains a combination of Clonazepam (0.5 mg) and Propranolol (20 mg), formulated to manage anxiety disorders, panic attacks, and certain cardiovascular conditions. Clonazepam, a benzodiazepine, exerts its therapeutic effects by enhancing the activity of gamma-aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system, thereby producing anxiolytic, anticonvulsant, and muscle-relaxant properties. Propranolol, a non-selective beta-adrenergic blocker, reduces heart rate, myocardial contractility, and blood pressure, making it effective in controlling physical symptoms associated with anxiety such as tachycardia, tremors, and hypertension. The combined action of these agents provides both central nervous system calming effects and peripheral cardiovascular stabilization. Klocalm-Plus is indicated for the treatment of generalized anxiety disorder, panic disorder, essential tremor, and certain types of arrhythmias. It should be used under strict medical supervision, considering potential contraindications such as respiratory disorders, bradycardia, and hypersensitivity to benzodiazepines or beta-blockers. Dosage must be individualized based on clinical response and patient tolerance. Caution is advised regarding sedation, withdrawal symptoms, and interactions with other CNS depressants. Regular monitoring of cardiovascular and neurological status is recommended during therapy to ensure safety and efficacy.